Under construction – not a live service
Sign in
Taking people in United StatesNo phase

Scrambler Therapy Compared With Standard Medicines for Pain After Stroke

Tests a device-based pain therapy against standard medicines in adults with pain after stroke.

Plain-language title generated from the registry record
Registry title: Scrambler Therapy for Post-Stroke Pain

Key facts

Where
Baltimore, United StatesSee the site

Where in United States

  • Johns Hopkins Bayview HospitalBaltimore, United StatesTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Johns Hopkins University
Trial code
NCT05563038
Record updated
26 January 2026
Original description
The Investigators will enroll patients who have had a stroke and are experiencing post-stroke pain secondary to their infarct and disruption of the sensory system in a research study to compare the effectiveness of Scrambler Therapy to traditional pharmacologic therapies.Read full original descriptionShow less

Scrambler Therapy for Post-Stroke Pain

The Investigators will enroll patients who have had a stroke and are experiencing post-stroke pain secondary to their infarct and disruption of the sensory system in a research study to compare the effectiveness of Scrambler Therapy to traditional pharmacologic therapies.

Inclusion: Men and women over the age of 18 with ischemic or hemorrhagic stroke seen on imaging and a positive finding for pain in the area(s) affected by their stroke location will be included; The patients must be at least one month post-stroke but can otherwise enroll at any point.

Exclusion: Patients with no evidence of stroke on MRI; Patients with history of myocardial infarction in the past 6 months; Patients with uncontrolled epilepsy; Patients with TIA; Patients with implantable devices such as pacemakers, defibrillators, spinal cord stimulators; Patients with symptomatic brain metastases.

ClinicalTrials.gov NCT05563038